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Genome-wide association studies (GWAS) have discovered hundreds of loci associated with complex 31 
brain disorders, and provide the best current insights into the etiology of these idiopathic traits. 32 
However, it remains unclear in which cell types these variants are active, which is essential for 33 
understanding etiology and subsequent experimental modeling. Here we integrate GWAS results with 34 
single-cell transcriptomic data from the entire mouse nervous system to systematically identify cell 35 
types underlying psychiatric disorders, neurological diseases, and brain complex traits. We show that 36 
psychiatric disorders are predominantly associated with cortical and hippocampal excitatory neurons, 37 
as well as medium spiny neurons from the striatum. Cognitive traits were generally associated with 38 
similar cell types but their associations were driven by different genes. Neurological diseases were 39 
associated with different cell types, which is consistent with other lines of evidence. Notably, we found 40 
that Parkinson’s disease is not only genetically associated with cholinergic and monoaminergic 41 
neurons (which include dopaminergic neurons from the substantia nigra) but also with neurons from 42 
the enteric system and oligodendrocytes. Using post-mortem brain transcriptomic data, we confirmed 43 
alterations in these cells, even at the earliest stages of disease progression. Our study provides an 44 
important framework for understanding the cellular basis of complex brain maladies, and reveals an 45 




Understanding the genetic basis of complex brain disorders is critical for identifying individuals at risk, 50 
designing prevention strategies, and developing rational therapeutics. In the last 50 years, twin 51 
studies have shown that psychiatric disorders, neurological diseases, and cognitive traits are strongly 52 
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influenced by genetic factors, explaining a mean of ~50% of the variance in liability 1, and GWAS 53 
have identified thousands of highly significant loci 2–5. However, interpretation of GWAS results 54 
remains challenging. First, >90% of the identified variants are located in non-coding regions 6, 55 
complicating precise identification of risk genes and mechanisms. Second, extensive linkage 56 
disequilibrium present in the human genome confounds efforts to pinpoint causal variants and the 57 
genes they influence . Finally, it remains unclear in which tissues and cell types these variants are 58 
active, and how they disrupt specific biological networks to impact disease risk.  59 
 60 
Functional genomic studies from brain are now seen as critical for interpretation of GWAS findings as 61 
they can identify functional regions (e.g., open chromatin, enhancers, transcription factor binding 62 
sites) and target genes (via chromatin interactions and eQTLs) 7. Gene regulation varies substantially 63 
across tissues and cell types 8,9, and hence it is critical to perform functional genomic studies in 64 
empirically identified cell types or tissues.  65 
 66 
Multiple groups have developed strategies to identify tissues associated with complex traits 10–14, but 67 
few have focused on the identification of salient cell types within a tissue. Furthermore, studies aiming 68 
to identify relevant cell types often used only a small number of cell types derived from one or few 69 
different brain regions 4,12–18. For example, we recently showed that, among 24 brain cell types, four 70 
types of neurons were consistently associated with schizophrenia 12. We were explicit that this 71 
conclusion was limited by the relatively few brain regions we studied; other cell types from unsampled 72 
regions could conceivably contribute to the disorder.  73 
 74 
Here, we integrate a wider range of gene expression data – tissues across the human body and 75 
single-cell gene expression data from an entire nervous system – to identify tissues and cell types 76 
underlying a large number of complex traits (Figure 1A,B). We expand on our prior work by showing 77 
that additional cell types are associated with schizophrenia. We also find that psychiatric and cognitive 78 
traits are generally associated with similar cell types whereas neurological disorders are associated 79 
with different cell types. Notably, we show that Parkinson’s disease is associated with cholinergic and 80 
monoaminergic neurons (as expected as these include dopaminergic neurons from the substantia 81 




Genetic correlations among complex traits 86 
 87 
Our goal was to use GWAS results to identify relevant tissues and cell types. Our primary focus was 88 
human phenotypes whose etiopathology is based in the central nervous system. We thus obtained 89 
18 sets of GWAS summary statistics from European samples for brain-related complex traits. These 90 
were selected because they had at least one genome-wide significant association (as of 2018; e.g., 91 
Parkinson’s disease, schizophrenia, and IQ). For comparison, we included GWAS summary statistics 92 
for 8 diseases and traits with large sample sizes whose etiopathology is not rooted in the central 93 
nervous system (e.g., type 2 diabetes). The selection of these conditions allowed contrasts of tissues 94 
and cells highlighted by our primary interest in brain phenotypes with non-brain traits. For Parkinson’s 95 
disease, we meta-analyzed summary statistics from a published GWAS 19 (9,581 cases, 33,245 96 
controls) with self-reported Parkinson’s disease from 23andMe (12,657 cases, 941,588 controls) after 97 
finding a high genetic correlation (𝑟") 20 between the samples (𝑟"=0.87, s.e=0.068). In this new meta-98 
analysis, we identified 61 independent loci associated with Parkinson’s disease (49 reported 99 
previously 18 and 12 novel) (Figure S1).  100 
 101 
We estimated the genetic correlations (𝑟") between these 26 traits. We confirmed prior reports 21,22 102 
that psychiatric disorders were strongly inter-correlated (e.g., high positive correlations for 103 
schizophrenia, bipolar disorder, and MDD) and shared little overlap with neurological disorders 104 
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(Figure S2 and Table S1). Parkinson’s disease was genetically correlated with intracranial volume 18 105 
(𝑟"=0.29, s.e=0.05) and amyotrophic lateral sclerosis (ALS, 𝑟"=0.19, s.e=0.08), while ALS was 106 
negatively correlated with intelligence (𝑟"=-0.24, s.e=0.06) and hippocampal volume (𝑟"=-0.24, 107 
s.e=0.12). These results indicate that there is substantial genetic heterogeneity across traits, which 108 
is a necessary (but not sufficient) condition for trait associations with different tissues or cell types.  109 
 110 
Association of traits with tissues using bulk-tissue RNA-seq 111 
 112 
We first aimed to identify the human tissues showing enrichment for genetic associations using bulk-113 
tissue RNA-seq (37 tissues) from GTEx 8 (Figure 1). To robustly identify the tissues implied by these 114 
26 GWAS, we used two approaches (MAGMA 23 and LDSC 13,24) which employ different assumptions 115 
(Methods). For both methods, we tested whether the 10% most specific genes in each tissue were 116 
enriched in genetic associations with the different traits (Figure 1B). 117 
 118 
Examination of non-brain traits found, as expected, associations with salient tissues. For example, as 119 
shown in Figure 1D and Table S2, inflammatory bowel disease was strongly associated with immune 120 
tissues (blood, spleen) and alimentary tissues impacted by the disease (small intestine and colon). 121 
Lung and adipose tissue were also significantly associated with inflammatory bowel disease, possibly 122 
because of the high specificity of immune genes in these two tissues (Figure S3). Type 2 diabetes 123 
was associated with the pancreas, while hemoglobin A1C, which is used to diagnose type 2 diabetes 124 
and monitor glycemic controls in diabetic patients, was associated with the pancreas, liver and 125 
stomach (Figure 1D). Stroke and coronary artery disease were most associated with blood vessels 126 
(Figure 1D, Figure S4) and waist to hip ratio was most associated with adipose tissue (Figure S4). 127 
Thus, our approach can identify the expected tissue associations given the pathophysiology of the 128 
different traits.  129 
 130 
For brain-related traits (Figure 1C, S4 and Table S2), 13 of 18 traits were significantly associated 131 
with one or more GTEx brain regions. For example, schizophrenia, intelligence, educational 132 
attainment, neuroticism, BMI and MDD were most significantly associated with brain cortex, frontal 133 
cortex or anterior cingulate cortex, while Parkinson’s disease was most significantly associated with 134 
the substantia nigra (as expected) and spinal cord (Figure 1C). Alzheimer’s disease was associated 135 
with tissues with prominent roles in immunity (blood and spleen) consistent with other studies 25–27, 136 
but also with the substantia nigra and spinal cord. Stroke was associated with blood vessel (consistent 137 
with a role of arterial pathology in stroke) 28. Traits with no or unexpected associations could occur 138 
because the primary GWAS had insufficient sample size for its genetic architecture 29 or because the 139 
tissue RNA-seq data omitted the correct tissue or cell type.  140 
 141 
In conclusion, we show that tissue-level gene expression allows identification of relevant tissues for 142 
complex traits, indicating that our methodology is suitable to explore trait-gene expression 143 
associations at the cell type level. 144 
 145 
Association of brain phenotypes with cell types from the mouse central and peripheral nervous system 146 
 147 
We leveraged gene expression data from 39 broad categories of cell types from the mouse central 148 
and peripheral nervous system 30 to systematically map brain-related traits to cell types (Figures 2A, 149 
S5). Our use of mouse data to inform human genetic findings was carefully considered (see 150 
Discussion).  151 
 152 
As in our previous study of schizophrenia based on a small number of brain regions 12, we found the 153 
strongest signals for telencephalon projecting neurons (i.e. excitatory neurons from the cortex, 154 
hippocampus and amygdala), telencephalon projecting inhibitory neurons (i.e. medium spiny neurons 155 
from the striatum) and telencephalon inhibitory neurons (Figure 2A and Table S3). We also found 156 
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that other types of neurons were associated with schizophrenia albeit less significantly (e.g., dentate 157 
gyrus granule neurons or hindbrain neurons). Other psychiatric and cognitive traits had similar cellular 158 
association patterns to schizophrenia (Figures S5-6 and Table S3). We did not observe any 159 
significant associations with immune or vascular cells for any psychiatric disorder or cognitive traits.  160 
 161 
Neurological disorders generally implicated fewer cell types, possibly because neurological GWAS 162 
had lower signal than GWAS of cognitive, anthropometric, and psychiatric traits (Figure S7). 163 
Consistent with the genetic correlations reported above, the pattern of associations for neurological 164 
disorders was distinct from psychiatric disorders (Figures S5-6), again reflecting that neurological 165 
disorders have minimal functional overlap with psychiatric disorders 21 (Figure S2). 166 
 167 
Stroke was significantly associated with vascular smooth muscle cells (Figure 2A) consistent with an 168 
important role of vascular processes for this trait. Amyotrophic lateral sclerosis (a motor neuron 169 
disease) was significantly associated with peripheral sensory neurofilament neurons, possibly 170 
because of transcriptomic similarities between peripheral sensory and motor neurons (which were not 171 
sampled) (Figure S5). Alzheimer’s disease had the strongest signal in microglia, as reported 172 
previously11,17,31, but the association did not survive multiple testing correction. 173 
 174 
We found that Parkinson’s disease was significantly associated with cholinergic and monoaminergic 175 
neurons (Figure 2A and Table S3). This cluster consists of neurons (Table S4) that are known to 176 
degenerate in Parkinson’s disease 32–34, such as dopaminergic neurons from the substantia nigra (the 177 
hallmark of Parkinson’s disease), but also serotonergic and glutamatergic neurons from the raphe 178 
nucleus 35, noradrenergic neurons 36, as well as neurons from afferent nuclei in the pons 37 and the 179 
medulla (the brain region associated with the earliest lesions in Parkinson’s disease 32). In addition, 180 
hindbrain neurons and peptidergic neurons were also significantly associated with Parkinson’s 181 
disease (with LDSC only). Therefore, our results capture expected features of Parkinson’s disease 182 
and suggest that biological mechanisms intrinsic to these neuronal cell types lead to their selective 183 
loss. Interestingly, we also found that enteric neurons were significantly associated with Parkinson’s 184 
disease (Figure 2A), which is consistent with Braak’s hypothesis, which postulates that Parkinson’s 185 
disease could start in the gut and travel to the brain via the vagus nerve 38,39. Furthermore, we found 186 
that oligodendrocytes (mainly sampled in the midbrain, medulla, pons, spinal cord and thalamus, 187 
Figure S8) were significantly associated with Parkinson’s disease, indicating a strong glial component 188 
to the disorder. This finding was unexpected but consistent with the strong association of the spinal 189 
cord at the tissue level (Figure 1C), as the spinal cord contains the highest proportion of 190 
oligodendrocytes (71%) in the nervous system 30. Altogether, these findings provide genetic evidence 191 
for a role of enteric neurons, cholinergic and monoaminergic neurons, as well as oligodendrocytes in 192 
Parkinson’s disease etiology. 193 
 194 
Neuronal prioritization in the mouse central nervous system 195 
 196 
A key goal of this study was to prioritize specific cell types for follow-up experimental studies. As our 197 
metric of gene expression specificity was computed based on all cell types in the nervous system, it 198 
is possible that the most specific genes in a given cell type capture genes that are shared within a 199 
high level category of cell types (e.g. neurons). To rule out this possibility, we computed new 200 
specificity metrics based only on neurons from the central nervous system (CNS). We then tested 201 
whether the top 10% most specific genes for each CNS neuron were enriched in genetic association 202 
for the brain related traits that had a significant association with a CNS neuron (13/18) in our initial 203 
analysis. 204 
 205 
Using the CNS neuron gene expression specificity metrics, we observed a reduction in the number 206 
of neuronal cell types associated with the different traits (Figure S9), suggesting that some of the 207 
signal was driven by core neuronal genes. For example, the association of telencephalon projecting 208 
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excitatory neurons with intracranial volume (Figure S5) was not significant using the CNS neuron 209 
specificity metric (Figure S9). However, we found that multiple neuronal cell types remained 210 
associated with a number of traits. For example, we found that telencephalon projecting excitatory 211 
and projecting inhibitory neurons were strongly associated with schizophrenia, bipolar disorder, 212 
educational attainment and intelligence using both LDSC and MAGMA. Similarly, telencephalon 213 
projecting excitatory neurons were significantly associated with BMI, neuroticism, MDD, autism and 214 
anorexia using one of the two methods (Figure S9), while hindbrain neurons and cholinergic and 215 
monoaminergic neurons remained significantly associated with Parkinson’s disease (Figure S9). 216 
 217 
Altogether, these results suggest that specific types of CNS neurons can be prioritized for follow-up 218 
experimental studies for multiple traits. 219 
 220 
Cell type-specific and trait-associated genes are enriched in specific biological functions 221 
 222 
Understanding which biological functions are dysregulated in different cell types is a key component 223 
of the etiology of complex traits. To obtain insights into the biological functions driving cell-type/trait 224 
associations, we evaluated GO term enrichment of genes that were specifically expressed (top 20% 225 
in a given cell type) and highly associated with a trait (top 10% MAGMA gene-level genetic 226 
association). Genes that were highly associated with schizophrenia and specific to telencephalon 227 
projecting excitatory neurons were enriched for GO terms related to neurogenesis, synapses, and 228 
voltage-gated channels (Table S5), suggesting that these functions may be fundamental to 229 
schizophrenia. Similarly, genes highly associated with educational attainment, intelligence, bipolar 230 
disorder, neuroticism,  BMI, anorexia and MDD and highly specific to their most associated cell types 231 
were enriched in terms related to neurogenesis, synaptic processes and voltage-gated channels 232 
(Table S5). In contrast, genes highly associated with stroke and specific to vascular cells were 233 
enriched in terms related to vasculature development, while genes highly associated with ALS and 234 
peripheral sensory neurofilament neurons were enriched in terms related to lysosomes.   235 
 236 
Genes highly associated with Parkinson’s disease and highly specific to cholinergic and 237 
monoaminergic neurons were significantly enriched in terms related to endosomes and synapses 238 
(Table S5). Similarly, genes highly specific to oligodendrocytes and Parkinson’s disease were 239 
enriched in endosomes. These results support the hypothesis that the endosomal pathway plays an 240 
important role in the etiology of Parkinson’s disease 40. 241 
 242 
Taken together, we show that cell type-trait associations are driven by genes belonging to specific 243 
biological pathways, providing insight into the etiology of complex brain related traits. 244 
 245 
Distinct traits are associated with similar cell types, but through different genes 246 
 247 
As noted above, the pattern of associations of psychiatric and cognitive traits were highly correlated 248 
across the 39 different cell types tested (Figure S6). For example, the Spearman rank correlation of 249 
cell type associations (-log10P) between schizophrenia and intelligence was 0.96 (0.94 for educational 250 
attainment) as both traits had the strongest signal in telencephalon projecting excitatory neurons and 251 
little signal in immune or vascular cells. In addition, we observed that genes driving the association 252 
signal in the top cell types of the two traits were enriched in relatively similar GO terms involving 253 
neurogenesis and synaptic processes. We evaluated two possible explanations for these findings: (a) 254 
schizophrenia and intelligence are both associated with the same genes that are specifically 255 
expressed in the same cell types or (b) schizophrenia and intelligence are associated with different 256 
sets of genes that are both highly specific to the same cell types. Given that these two traits have a 257 
significant negative genetic correlation (𝑟"=-0.22, from GWAS results alone) (Figure S2 and Table 258 
S1), we hypothesized that the strong overlap in cell type associations for schizophrenia and 259 
intelligence was due to the second explanation.  260 
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 261 
To evaluate these hypotheses, we tested whether the 10% most specific genes for each cell type 262 
were enriched in genetic association for schizophrenia controlling for the gene-level genetic 263 
association of intelligence using MAGMA. We found that the pattern of associations were largely 264 
unaffected by controlling the schizophrenia cell type association analysis for the gene-level genetic 265 
association of intelligence and vice versa (Figure S10). Similarly, we found that controlling for 266 
educational attainment had little effect on the schizophrenia associations and vice versa (Figure S11). 267 
In other words, genes driving the cell type associations of schizophrenia appear to be distinct from 268 
genes driving the cell types associations of cognitive traits.  269 
 270 
Multiple cell types are independently associated with brain complex traits 271 
 272 
Many neuronal cell types passed our stringent significance threshold for multiple brain traits (Figure 273 
2A and S5). This could be because gene expression profiles are highly correlated across cell types 274 
and/or because many cell types are independently associated with the different traits. In order to 275 
address this, we performed univariate conditional analysis using MAGMA, testing whether cell type 276 
associations remained significant after controlling for the 10% most specific genes from other cell 277 
types (Table S6). We observed that multiple cell types were independently associated with age at 278 
menarche, anorexia, autism, bipolar, BMI, educational attainment, intelligence, MDD, neuroticism and 279 
schizophrenia (Figure S12). As in our previous study 12, we found that the association between 280 
schizophrenia and telencephalon projecting inhibitory neurons (i.e. medium spiny neurons) appears 281 
to be independent from telencephalon projecting excitatory neurons (i.e. pyramidal neurons). For 282 
Parkinson’s disease, we found that enteric neurons, oligodendrocytes and cholinergic and 283 
monoaminergic neurons were independently associated with the disorder (Figure 2B), suggesting 284 
that these three different cell types play an independent role in the etiology of the disorder. 285 
 286 
Replication in other single-cell RNA-seq datasets 287 
 288 
To assess the robustness of our results, we repeated these analyses in independent RNA-seq 289 
datasets. A key caveat is that these other datasets did not sample the entire nervous system as in 290 
the analyses above.  291 
 292 
First, we used a single-cell RNA-seq dataset that identified 88 broad categories of cell types (565 293 
subclusters) in 690K single cells from 9 mouse brain regions (frontal cortex, striatum, globus pallidus 294 
externus/nucleus basalis, thalamus, hippocampus, posterior cortex, entopeduncular 295 
nucleus/subthalamic nucleus, substantia nigra/ventral tegmental area, and cerebellum) 41. We found 296 
similar patterns of association in this external dataset (Figure 3A, S14 and Table S7). Notably, for 297 
schizophrenia, we strongly replicated associations with neurons from the cortex, hippocampus and 298 
striatum. We also observed similar cell type associations for other psychiatric and cognitive traits 299 
(Figure 3A, S13, S14 and S15). For neurological disorders, we found that stroke was significantly 300 
associated with mural cells while Alzheimer’s disease was significantly associated with microglia 301 
(Figure S14). The associations of Parkinson’s disease with neurons from the substantia nigra and 302 
oligodendrocytes were significant at a nominal level in this dataset (P=0.006 for neurons from the 303 
substantia nigra, P=0.027 for oligodendrocytes using LDSC) (Table S3). By computing gene 304 
expression specificity within neurons, we replicated our previous findings that neurons from the cortex 305 
can be prioritized for multiple traits (schizophrenia, bipolar, educational attainment, intelligence, BMI, 306 
neuroticism, MDD, anorexia) (Figure S16). 307 
 308 
Second, we reanalyzed these GWAS datasets using our previous single-cell RNA-seq dataset (24 309 
cell types from the neocortex, hippocampus, striatum, hypothalamus midbrain, and specific 310 
enrichments for oligodendrocytes, serotonergic neurons, dopaminergic neurons and cortical 311 
parvalbuminergic interneurons, 9970 single cells; Figure 3B, S17 and Table S8). We again found 312 
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strong associations of pyramidal neurons from the somatosensory cortex, pyramidal neurons from 313 
the CA1 region of the hippocampus (both corresponding to telencephalon projecting excitatory 314 
neurons in our main dataset), and medium spiny neurons from the striatum (corresponding to 315 
telencephalon projecting inhibitory neurons) with psychiatric and cognitive traits. MDD and autism 316 
were most associated with neuroblasts, while intracranial volume was most associated with neural 317 
progenitors (suggesting that drivers of intracranial volume are cell types implicated in increasing cell 318 
mass). The association of dopaminergic adult neurons with Parkinson’s disease was significant at a 319 
nominal level using LDSC (P=0.01), while oligodendrocytes did not replicate in this dataset, perhaps 320 
because they were not sampled from the regions affected by the disorder (i.e. spinal cord, pons, 321 
medulla or midbrain). A within-neuron analysis again found that projecting excitatory (i.e. pyramidal 322 
CA1) and projecting inhibitory neurons (i.e. medium spiny neurons) can be prioritized for multiple 323 
traits (schizophrenia, bipolar, intelligence, educational attainment, BMI). In addition, we found that 324 
neuroblasts could be prioritized for MDD and that neural progenitors could be prioritized for 325 
intracranial volume (Figure S18) in this dataset.  326 
 327 
Third, we evaluated a human single-nuclei RNA-seq dataset consisting of 15 different cell types from 328 
cortex and hippocampus 42 (Figure 4A and Table S9). We replicated our findings with psychiatric and 329 
cognitive traits being associated with pyramidal neurons (excitatory) and interneurons (inhibitory) from 330 
the somatosensory cortex and from the CA1 region of the hippocampus. We also replicated the 331 
association of Parkinson’s disease with oligodendrocytes (enteric neurons and cholinergic and 332 
monoaminergic neurons were not sampled in this dataset). No cell types reached our significance 333 
threshold using specificity metrics computed within-neurons, possibly because of similarities in the 334 
transcriptomes of neurons from the cortex and hippocampus. 335 
 336 
Fourth, we evaluated a human single-nuclei RNA-seq dataset consisting of 31 different cell types 337 
from 3 different brain regions (visual cortex, frontal cortex and cerebellum) (Figure 4B and Table 338 
S10). We found that schizophrenia, educational attainment, neuroticism and BMI were associated 339 
with excitatory neurons, while bipolar was associated with both excitatory and inhibitory neurons. As 340 
observed previously 11,17,31, Alzheimer’s disease was significantly associated with microglia. 341 
Oligodendrocytes were not significantly associated with Parkinson’s disease in this dataset, again 342 
possibly because the spinal cord, pons, medulla and midbrain were not sampled. No cell types 343 
reached our significance threshold using specificity metrics computed within neurons in thid dataset. 344 
 345 
Most cell type-trait associations were attenuated using human single-nuclei data compared with 346 
mouse single-cell RNA-seq data, suggesting that the transcripts that are lost by single-nuclei RNA-347 
seq are important for a large number of disorders and/or that the controlled condition of mouse 348 
experiments provide more accurate gene expression quantifications (see Discussion and Figure 349 
S19).  350 
 351 
Comparison with case/control differentially expressed genes at the cell type level 352 
 353 
We compared our findings for Alzheimer’s disease (Table S3, Figure 4B, Figure S14) with a recent 354 
study that performed differential expression analysis at the cell type level between 24 Alzheimer’s 355 
cases and 24 controls 43 (prefrontal cortex, Brodmann area 10). We tested whether the top 500, top 356 
1000 and top 2000 most differentially expressed genes (no pathology vs pathology) in six different 357 
cell types (excitatory neurons, inhibitory neurons, oligodendrocytes, oligodendrocytes precursor cells, 358 
astrocyte and microglia) were enriched in genetic associations with Alzheimer’s disease using 359 
MAGMA. Consistently with our results, we found that genes differentially expressed in microglia were 360 
the most associated with Alzheimer’s disease genetics (Table S11), indicating that our approach 361 
appropriately highlight the relevant cell type at a fraction of the cost of a case-control single cell RNA-362 
seq study. As performing case-control single cell RNA-seq studies in the entire nervous system is 363 
currently cost prohibitive, the consistency of our results with the case-control study of Alzheimer’s 364 
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disease suggests that our results could be leveraged to target specific brain regions and cell types in 365 
future case-control genomic studies of brain disorders. 366 
 367 
Validation of oligodendrocyte pathology in Parkinson’s disease 368 
 369 
We investigated the role of oligodendrocyte lineage cells in Parkinson’s disease. First, we confirmed 370 
the association of oligodendrocytes with Parkinson’s disease by combining evidence across all 371 
datasets (Fisher’s combined probability test, P=2.5*10-7 using MAGMA and 6.3*10-3 using LDSC) 372 
(Table S3 and Figure S20). Second, we tested whether oligodendrocytes were significantly 373 
associated with Parkinson’s disease conditioning on the top neuronal cell type in the different datasets 374 
using MAGMA and found: (a) that oligodendrocytes were independently associated from the top 375 
neuronal cell type in our main dataset and in the Habib replication dataset 42 at a Bonferroni significant 376 
level (P=7.3*10-5 and P=1.7*10-4 respectively), (b) nominal evidence in the Saunders dataset 44 377 
(P=0.018), (c) weak evidence in the Skene 12 (P=0.12) and Lake 45 datasets (P=0.2) and (d) combining 378 
the conditional evidence from all datasets, oligodendrocytes were significantly associated with 379 
Parkinson’s disease independently of the top neuronal association (P=1.2*10-7, Fisher’s combined 380 
probability test).  381 
 382 
Third, we tested whether genes with rare variants associated with Parkinsonism (Table S12) were 383 
specifically expressed in cell types from the mouse nervous system (Method). As for the common 384 
variant, we found the strongest enrichment for cholinergic and monoaminergic neurons (Table S13). 385 
However, we did not observe any significant enrichments for oligodendrocytes or enteric neurons 386 
using genes associated with rare variants in Parkinsonism. 387 
 388 
Fourth, we applied EWCE 11 to test whether genes that are up/down-regulated in human post-mortem 389 
Parkinson’s disease brains (from six separate cohorts) were enriched in cell types located in the 390 
substantia nigra and ventral midbrain (Figure 5). Three of the studies had a case-control design and 391 
measured gene expression in: (a) the substantia nigra of 9 controls and 16 cases 46, (b) the medial 392 
substantia nigra of 8 controls and 15 cases 47, and (c) the lateral substantia nigra of 7 controls and 9 393 
cases 47. In all three studies, downregulated genes in Parkinson’s disease were specifically enriched 394 
in dopaminergic neurons (consistent with the loss of this particular cell type in disease), while 395 
upregulated genes were significantly enriched in cells from the oligodendrocyte lineage. This 396 
suggests that an increased oligodendrocyte activity or proliferation could play a role in Parkinson’s 397 
disease etiology. Surprisingly, no enrichment was observed for microglia, despite recent findings 48,49. 398 
 399 
We also analyzed gene expression data from post-mortem human brains which had been scored by 400 
neuropathologists for their Braak stage 50. Differential expression was calculated between brains with 401 
Braak scores of zero (controls) and brains with Braak scores of 1—2, 3—4 and 5—6. At the latter 402 
stages (Braak scores 3—4 and 5—6), downregulated genes were specifically expressed in 403 
dopaminergic neurons, while upregulated genes were specifically expressed in oligodendrocytes 404 
(Figure 5), as observed in the case-control studies. Moreover, Braak stage 1 and 2 are characterized 405 
by little degeneration in the substantia nigra and, consistently, we found that downregulated genes 406 
were not enriched in dopaminergic neurons at this stage. Notably, upregulated genes were already 407 
strongly enriched in oligodendrocytes at Braak Stages 1-2. These results not only support the genetic 408 
evidence indicating that oligodendrocytes may play a causal role in Parkinson’s disease, but indicate 409 




In this study, we used gene expression data from cells sampled from the entire nervous system to 414 
systematically map cell types to GWAS results from multiple psychiatric, cognitive, and neurological 415 
complex phenotypes.  416 
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 417 
We note several limitations. First, we again emphasize that we can implicate a particular cell type but 418 
it is premature to exclude cell types for which we do not have data 12. Second, we used gene 419 
expression data from mouse to understand human phenotypes. We believe our approach is 420 
appropriate for several reasons. (A) Crucially, the key findings replicated in human data. (B) Single-421 
cell RNA-seq is achievable in mouse but difficult in human neurons (where single-nuclei RNA-seq is 422 
typical 42,45,51,52). In brain, differences between single-cell and single-nuclei RNA-seq are important as 423 
transcripts that are missed by sequencing nuclei are important for psychiatric disorders, and we 424 
previously showed that dendritically-transported transcripts (important for schizophrenia) are 425 
specifically depleted from nuclei datasets 12 (we confirmed this finding in four additional datasets, 426 
Figure S19). (C) Correlations in gene expression for cell type across species is high (median 427 
correlation 0.68, Figure S21), and as high or higher than correlations across methods within cell type 428 
and species (single-cell vs single-nuclei RNA-seq, median correlation 0.6) 53. (D) We evaluated 429 
protein-coding genes with 1:1 orthologs between mouse and human. These constitute most human 430 
protein-coding genes, and these genes are generally highly conserved particularly in the nervous 431 
system. We did not study genes present in one species but not in the other. (E) More specifically, we 432 
previously showed that gene expression data cluster by cell type and not by species 12, indicating 433 
broad conservation of core brain cellular functions across species. (F) We used a large number of 434 
genes to map cell types to traits (~1500 genes for each cell type), minimizing potential bias due to 435 
individual genes differentially expressed across species. (G) If there were strong differences in cell 436 
type gene expression between mouse and human, we would not expect that specific genes in mouse 437 
cell types would be enriched in genetic associations with human disorders. However, it remains 438 
possible that some cell types have different gene expression patterns between mouse and human, 439 
are only present in one species, have a different function or are involved in different brain circuits.  440 
 441 
A third limitation is that gene expression data were from adolescent mice. Although many psychiatric 442 
and neurological disorders have onsets in adolescence, some have onsets earlier (autism) or later 443 
(Alzheimer’s and Parkinson's disease). It is thus possible that some cell types are vulnerable at 444 
specific developmental times. Data from studies mapping cell types across brain development and 445 
aging are required to resolve this issue. 446 
 447 
For schizophrenia, we replicated and extended our previous findings 12. We found the most significant 448 
associations for neurons located in the cortex, hippocampus and striatum (Figure 2A, 3) in multiple 449 
independent datasets, and showed that these neuronal cell types can be prioritized among neurons 450 
(Figure S9, S16 and S18). These results are consistent with the strong schizophrenia heritability 451 
enrichment observed in open chromatin regions from: human dorsolateral prefrontal cortex 54; human 452 
cortical, striatal and hippocampal neurons 55; and mouse open chromatin regions from cortical 453 
excitatory and inhibitory neurons 56. This degree of replication in independent transcriptomic datasets 454 
from multiple groups along with consistent findings using orthogonal open chromatin data is notable, 455 
and strongly implicates these cell types in the etiology of schizophrenia.  456 
 457 
Moreover, we found that other psychiatric traits implicated largely similar cell types. These biological 458 
findings are consistent with genetic and epidemiological evidence of a general psychopathy factor 459 
underlying diverse clinical psychiatric disorders 21,57,58. Although intelligence and educational 460 
attainment implicated similar cell types, conditional analyses showed that the same cell types were 461 
implicated for different reasons. This suggests that different sets of genes highly specific to the same 462 
cell types contribute independently to schizophrenia and cognitive traits.  463 
 464 
A number of studies have argued that the immune system plays a causal role in some psychiatric 465 
disorders 59,60. Our results did not implicate any brain immune cell types in psychiatric disorders. We 466 
interpret these negative findings cautiously as we did not fully sample the immune system. It is also 467 
possible that a small number of genes are active in immune cell types and that these cell types play 468 
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an important role in the etiology of psychiatric disorders. Finally, if immune functions are salient for a 469 
small subset of patients, GWAS may not identify these loci without larger and more detailed studies.  470 
 471 
Our findings for neurological disorders were strikingly different from psychiatric disorders. In contrast 472 
to previous studies that either did not identify any cell type associations with Parkinson’s disease 61 473 
or identified significant associations with cell types from the adaptive immune system 49, we found 474 
that cholinergic and monoaminergic neurons (which include dopaminergic neurons), enteric neurons 475 
and oligodendrocytes were significantly and independently associated with the disease. It is well 476 
established that loss of dopaminergic neurons in the substantia nigra is a hallmark of Parkinson’s 477 
disease. Our findings suggest that dopaminergic neuron loss in Parkinson’s disease is at least partly 478 
due to intrinsic biological mechanisms. In addition, other type of cholinergic and monoaminergic 479 
neurons are known to degenerate in Parkinson’s disease (e.g., raphe nucleus serotonergic neurons 480 
and cholinergic neurons of the pons), suggesting that specific pathological mechanisms may be 481 
shared across these neurons and lead to their degeneration. Two theories for the selective 482 
vulnerability of neuronal populations in Parkinson’s disease currently exist: the “spread Lewy 483 
pathology model” which assumes cell-to-cell contacts enabling spreading of prion-like α-synuclein 484 
aggregates 62; and the “threshold theory” 63,64 which proposes that the vulnerable cell types 485 
degenerate due to molecular/functional biological similarities in a cell-autonomous fashion. While both 486 
theories are compatible and can co-exist, our findings support the existence of cell autonomous 487 
mechanisms contributing to selective vulnerability. We caution that we do not know if all cholinergic 488 
and monoaminergic neurons show degeneration or functional impairment. However, analysis of the 489 
cellular mechanisms driving the association of cholinergic and monoaminergic neurons with 490 
Parkinson’s disease revealed endosomal trafficking as a plausible common pathogenic mechanism. 491 
 492 
Interestingly, enteric neurons were also associated with Parkinson’s disease. This result is in line with 493 
prior evidence implicating the gut in Parkinson’s disease. Notably, dopaminergic defects and Lewy 494 
bodies (i.e. abnormal aggregates of proteins enriched in α-synuclein) are found in the enteric nervous 495 
system of patients affected by Parkinson’s disease 65,66. In addition, Lewy bodies have been observed 496 
in patients up to 20 years prior to their diagnosis 67 and sectioning of the vagus nerve (which connects 497 
the enteric nervous system to the central nervous system) was shown to reduce the risk of developing 498 
Parkinson’s disease 68. Therefore, our results linking enteric neurons with Parkinson’s disease 499 
provides new genetic evidence for Braak’s hypothesis, which postulates that Parkinson’s disease 500 
could start in the gut, travel along the vagus nerve, and affect the brain years after disease initiation 501 
38. 502 
 503 
The association of oligodendrocytes with Parkinson’s disease was more unexpected. A possible 504 
explanation is that this association could be due to a related disorder (e.g., multiple system atrophy, 505 
characterized by Parkinsonism and accumulation of α-synuclein in glial cytoplasmic inclusions 69). 506 
However, this explanation is unlikely as multiple system atrophy is a very rare disorder; hence, only 507 
a few patients are likely to have been included in the Parkinson’s disease GWAS which could not 508 
have affected the GWAS results. In addition, misdiagnosis is unlikely to have led to the association 509 
of Parkinson’s disease with oligodendrocytes. Indeed, we found a high genetic correlation between 510 
self-reported diagnosis from the 23andMe cohort and a previous GWAS of clinically-ascertained 511 
Parkinson’s disease 19. In addition, self-report of Parkinson’s disease in 23andMe subjects was 512 
confirmed by a neurologist in all 50 cases evaluated 70.  513 
 514 
We did not find an association of oligodendrocytes with Parkinsonism for genes affected by rare 515 
variants. This result may reflect etiological differences between sporadic and familial forms of the 516 
disease or the low power and insufficient number of genes tested. Prior evidence has suggested an 517 
involvement of oligodendrocytes in Parkinson’s disease. For example, α-synuclein-containing 518 
inclusions have been reported in oligodendrocytes in Parkinson’s disease brains 71. These inclusions 519 
(“coiled bodies”) are typically found throughout the brainstem nuclei and fiber tracts 72. Although the 520 
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presence of coiled bodies in oligodendrocytes is a common, specific, and well-documented 521 
neuropathological feature of Parkinson’s disease, the importance of this cell type and its early 522 
involvement in disease has not been fully recognized. Our findings suggest that intrinsic genetic 523 
alterations in oligodendrocytes occur at an early stage of disease, which precedes the emergence of 524 
neurodegeneration in the substantia nigra, arguing for a key role of this cell type in Parkinson’s 525 
disease etiology.  526 
 527 
Taken together, we integrated genetics and single-cell gene expression data from the entire nervous 528 
system to systematically identify cell types underlying brain complex traits. We believe that this a 529 
critical step in the understanding of the etiology of brain disorders and that these results will guide 530 




GWAS results 535 
Our goal was to use GWAS results to identify relevant tissues and cell types. Our primary focus was 536 
human phenotypes whose etiopathology is based in the central nervous system. We thus obtained 537 
18 sets of GWAS summary statistics from European samples for brain-related complex traits. These 538 
were selected because they had at least one genome-wide significant association (as of 2018; e.g., 539 
Parkinson’s disease, schizophrenia, and IQ). For comparison, we included GWAS summary statistics 540 
for 8 diseases and traits with large sample sizes whose etiopathology is not rooted in the central 541 
nervous system (e.g., type 2 diabetes). The selection of these conditions allowed contrasts of tissues 542 
and cells highlighted by our primary interest in brain phenotypes with non-brain traits.  543 
 544 
The phenotypes were: schizophrenia 2, educational attainment 3, intelligence 15, body mass index 5, 545 
bipolar disorder 73, neuroticism 4, major depressive disorder 74, age at menarche 75, autism 76, migraine 546 
77, amyotrophic lateral sclerosis 78, ADHD 79, Alzheimer’s disease 26, age at menopause 80, coronary 547 
artery disease 81, height 5, hemoglobin A1c 82, hippocampal volume 83, inflammatory bowel disease 548 
84, intracranial volume 85, stroke 86, type 2 diabetes mellitus 87, type 2 diabetes adjusted for BMI 87, 549 
waist-hip ratio adjusted for BMI 88, and anorexia nervosa 89.  550 
 551 
For Parkinson’s disease, we performed an inverse variance-weighted meta-analysis 90 using 552 
summary statistics from Nalls et al. 19 (9,581 cases, 33,245 controls) and summary statistics from 553 
23andMe (12,657 cases, 941,588 controls). We found a very high genetic correlation (𝑟") 20 between 554 
results from these cohorts (𝑟"=0.87, s.e=0.068) with little evidence of sample overlap (LDSC bivariate 555 
intercept=0.0288, s.e=0.0066). The P-values from the meta-analysis strongly deviated from the 556 
expected (Figure S22) but was consistent with polygenicity (LDSC intercept=1.0048, s.e=0.008) 557 
rather than uncontrolled inflation 20.  558 
 559 
Gene expression data 560 
We collected publicly available single-cell RNA-seq data from different studies. The core dataset of 561 
our analysis is a study that sampled more than 500K single cells from the entire mouse nervous 562 
system (19 regions) and identified 39 broad categories (level 4) and 265 refined cell types (level 5) 563 
30. The 39 cell types expressed a median of 16417 genes, had a median UMI total count of ~8.6M 564 
and summed the expression of a median of 1501 single cells (Table S14). The replication datasets 565 
were: 1) a mouse study that sampled 690K single cells from 9 brain regions and identified 565 cell 566 
types 91 (note that we averaged the UMI counts by broad categories of cell type in each brain region, 567 
resulting in 88 different cell types); 2) our prior mouse study of ~10K cells from 5 different brain regions 568 
(and samples enriched for oligodendrocytes, dopaminergic neurons, serotonergic neurons and 569 
cortical parvalbuminergic interneurons) that identified 24 broad categories and 149 refined cell types 570 
12; 3) a study that sampled 19,550 nuclei from frozen adult human post-mortem hippocampus and 571 
prefrontal cortex and identified 16 cell types 42; 4) a study that generated 36,166 single-nuclei 572 
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expression measurements (after quality control) from the human visual cortex, frontal cortex and 573 
cerebellum 45. We also obtained bulk tissues RNA-seq gene expression data from 53 tissues from the 574 
GTEx consortium 8 (v8, median across samples).  575 
 576 
Gene expression data processing 577 
All datasets were processed uniformly. First we computed the mean expression for each gene in each 578 
cell type from the single-cell expression data (if this statistics was not provided by the authors). We 579 
used the pre-computed median expression across individuals for the GTEx dataset and excluded 580 
tissues that were not sampled in at least 100 individuals, non-natural tissues (e.g. EBV-transformed 581 
lymphocytes) and testis (outlier using hierarchical clustering). We then averaged the expression of 582 
tissues by organ (with the exception of brain tissues) resulting in gene expression profiles of a total 583 
of 37 tissues. For all datasets, we filtered out any genes with non-unique names, genes not expressed 584 
in any cell types, non-protein coding genes, and, for mouse datasets, genes that had no expert 585 
curated 1:1 orthologs between mouse and human (Mouse Genome Informatics, The Jackson 586 
laboratory, version 11/22/2016). Gene expression was then scaled to a total of 1M UMIs (or transcript 587 
per million (TPM)) for each cell type/tissue. We then calculated a metric of gene expression specificity 588 
by dividing the expression of each gene in each cell type by the total expression of that gene in all 589 
cell types, leading to values ranging from 0 to 1 for each gene (0: meaning that the gene is not 590 
expressed in that cell type, 0.6: that 60% of the total expression of that gene is performed in that cell 591 
type, 1: that 100% of the expression of that gene is performed in that cell type). The top 10% most 592 
specific genes (Table S15 and Table S16) in each tissue/cell type partially overlapped for related 593 
tissues/cell types, did not overlap for unrelated tissue/cell types and allowed to cluster related 594 
tissues/cell types as expected (Figure S23 and Figure S24). 595 
 596 
MAGMA primary and conditional analyses 597 
MAGMA (v1.06b) 23 is a software for gene-set enrichment analysis using GWAS summary statistics. 598 
Briefly, MAGMA computes a gene-level association statistic by averaging P-values of SNPs located 599 
around a gene (taking into account LD structure). The gene-level association statistic is then 600 
transformed to a Z-value. MAGMA can then be used to test whether a gene set is a predictor of the 601 
gene-level association statistic of the trait (Z-value) in a linear regression framework. MAGMA 602 
accounts for a number of important covariates such as gene size, gene density, mean sample size 603 
for tested SNPs per gene, the inverse of the minor allele counts per gene and the log of these metrics.  604 
 605 
For each GWAS summary statistics, we excluded any SNPs with INFO score <0.6, with MAF < 1% 606 
or with estimated odds ratio > 25 or smaller than 1/25, the MHC region (chr6:25-34 Mb) for all GWAS 607 
and the APOE region (chr19:45020859–45844508) for the Alzheimer’s GWAS. We set a window of 608 
35kb upstream to 10kb downstream of the gene coordinates to compute gene-level association 609 
statistics and used the European reference panel from the phase 3 of the 1000 genomes project 92 610 
as the reference population. For each trait, we then used MAGMA to test whether the 10% most 611 
specific gene in each tissue/cell type was associated with gene-level genetic association with the trait. 612 
Only genes with at least 1TPM or 1 UMI per million in the tested cell type were used for this analysis. 613 
The significance level of the different cell types was highly correlated with the effect size of the cell 614 
type (Figure S25) with values ranging between 0.999 and 1 across the 18 brain related traits in the 615 
Zeisel et al. dataset 93. The significance threshold was set to a 5% false discovery rate across all 616 
tissues/cell types and traits within each dataset. 617 
 618 
MAGMA can also perform conditional analyses given its linear regression framework. We used 619 
MAGMA to test whether cell types were associated with a specific trait conditioning on the gene-level 620 
genetic association of another trait (Z-value from MAGMA .out file) or to look for associations of cell 621 
types conditioning on the 10% most specific genes from other cell types by adding these variables as 622 
covariate in the model. 623 
 624 
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To test whether MAGMA was well-calibrated, we randomly permuted the gene labels of the 625 
schizophrenia gene-level association statistic file a thousand times. We then looked for association 626 
between the 10% most specific genes in each cell type and the randomized gene-level schizophrenia 627 
association statistics. We observed that MAGMA was slightly conservative with less than 5% of the 628 
random samplings having a P-value <0.05 (Figure S26). 629 
 630 
We also evaluated the effect of varying window sizes (for the SNPs to gene assignment step of 631 
MAGMA) on the schizophrenia cell type associations strength (-log10(P)). We observed strong 632 
Pearson correlations in cell type associations strength (-log10(P)) across the different window sizes 633 
tested (Figure S27). Our selected window size (35kb upstream to 10 kb downstream) had Pearson 634 
correlations ranging from 0.94 to 0.98 with the other window sizes, indicating that our results are 635 
robust to this parameter. 636 
 637 
In a recent paper, Watanabe et al. 94 introduced a different methodology to test for cell type – complex 638 
trait association based on MAGMA. Their proposed methodology tests for a positive relationship 639 
between gene expression levels and gene-level genetic associations with a complex trait (using all 640 
genes). Their method uses the average expression of each gene in all cell types in the dataset as a 641 
covariate. We examined the method of Watanabe et al. in detail, and decided against its use for 642 
multiple reasons.  643 
 644 
First, Watanabe et al. hypothesize that genes with higher levels of expression should be more 645 
associated with a trait. In extended discussions among our team (which include multiple 646 
neuroscientists), we have strong reservations about the appropriateness and biological 647 
meaningfulness of this hypothesis; it is a strong requirement and is at odds with decades of 648 
neuroscience research where molecules expressed a low levels can have profound biological impact. 649 
For instance, many cell-type specific genes that are disease relevant are expressed at moderate 650 
levels (e.g., Drd2 is in the 10% most specific genes in telencephalon projecting inhibitory neurons but 651 
in the bottom 30% of expression levels). Our method does not make this hypothesis.  652 
 653 
Second, the method of Watanabe et al. corrects for the average expression of all cell types in a 654 
dataset. This practice is, in our view, problematic as it necessarily forces dependence on the 655 
composition of a scRNA-seq dataset. For instance, if a dataset consists mostly of neurons, this 656 
amounts to correcting for neuronal expression and necessarily erodes power to detect trait 657 
enrichment in neurons. Alternatively, if a dataset is composed mostly of non-neuronal cells, this will 658 
impacts the detection of enrichment in non-neuronal cells. 659 
 660 
Third, preliminary results indicate that the method of Watanabe et al. is sensitive to scaling. As 661 
different cell types express different numbers of genes, scaling to the same total read counts affects 662 
the average gene expression across cell types (which they use as a covariate), leading to different 663 
results with different choices of scaling factors (e.g., scaling to 10k vs 1 million reads). Our method is 664 
not liable to this issue. 665 
 666 
LD score regression analysis 667 
We used partitioned LD score regression 95 to test whether the top 10% most specific genes of each 668 
cell type (based on our specificity metric described above) were enriched in heritability for the diverse 669 
traits. Only genes with at least 1TPM or 1 UMI per million in the tested cell type were used for this 670 
analysis. In order to capture most regulatory elements that could contribute to the effect of the region 671 
on the trait, we extended the gene coordinates by 100kb upstream and by 100kb downstream of each 672 
gene as previously 13. SNPs located in 100kb regions surrounding the top 10% most specific genes 673 
in each cell type were added to the baseline model (consisting of 53 different annotations) 674 
independently for each cell type (one file for each cell type). We then selected the coefficient z-score 675 
p-value as a measure of the association of the cell type with the traits. The significance threshold was 676 
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set to a 5% false discovery rate across all tissues/cell types and traits within each dataset. All plots 677 
show the mean -log10(P) of partitioned LDscore regression and MAGMA. All results for MAGMA or 678 
LDSC are available in supplementary data files.  679 
 680 
We evaluated the effect of varying window sizes and varying the percentage of most specific genes 681 
on the schizophrenia cell type associations strength (-log10P). We observed strong Pearson 682 
correlations in cell type associations strength (-log10P) across the different percentage and window 683 
sizes tested (Figure S28). Our selected window size (100 kb upstream to 100 kb downstream, top 684 
10% most specific genes) had Pearson correlations ranging from 0.96 to 1 with the other window 685 
sizes and percentage, indicating that our results are robust to these parameters. 686 
 687 
MAGMA vs LDSC ranking 688 
In order to test whether the cell type ranking obtained using MAGMA and LDSC in the Zeisel et al. 689 
dataset 30 were similar, we computed the Spearman rank correlation of the cell types association 690 
strength (-log10P) between the two methods for each complex trait. The Spearman rank correlation 691 
was strongly correlated with 𝜆$%  (a measure of the deviation of the GWAS test statistics from the 692 
expected) (Spearman r=0.89) (Figure S29) and with the average number of cell types below our 693 
stringent significance threshold (Spearman r=0.92), indicating that the overall ranking of the cell types 694 
is very similar between the two methods, provided that the GWAS is well powered (Figure S30). In 695 
addition, we found that 𝜆$% was strongly correlated with the strength of association of the top tissue 696 
(-log10P) (Spearman r=0.88) (Figure S31), as well as with the effect size (beta) of the top tissue 697 
(Spearman r=0.9), indicating that cell type – trait associations are stronger for well powered GWAS. 698 
The significance level (-log10P)  was also strongly correlated with the effect size (Spearman r=0.996) 699 
(Figure S31) for the top cell type of each trait. 700 
 701 
 702 
Dendritic depletion analysis 703 
This analysis was performed as previously described 12. In brief, all datasets were reduced to a set of 704 
six common cell types: pyramidal neurons, interneurons, astrocytes, microglia and oligodendrocyte 705 
precursors. Specificity was recalculated using only these six cell types. Comparisons were then made 706 
between pairs of datasets (denoted in the graph with the format ‘X versus Y’). The difference in 707 
specificity for a set of dendrite enriched genes is calculated between the datasets. Differences in 708 
specificity are also calculated for random sets of genes selected from the background gene set. The 709 
probability and z-score for the difference in specificity for the dendritic genes is thus estimated. 710 
Dendritically enriched transcripts were obtained from Supplementary Table 10 of Cajigas et al. 96. For 711 
the KI dataset 12, we used S1 pyramidal neurons. For the Zeisel 2018 dataset 30 we used all ACTE* 712 
cells as astrocytes, TEGLU* as pyramidal neurons, TEINH* as interneurons, OPC as oligodendrocyte 713 
precursors and MGL* as microglia. For the Saunders dataset 41, we used all Neuron.Slc17a7 cellt 714 
ypes from FC, HC or PC as pyramidal neurons; all Neuron.Gad1Gad2 cell types from FC, HC or PC 715 
as interneurons; Polydendrocye as OPCs; Astrocyte as astrocytes, and Microglia as microglia. The 716 
Lake datasets both came from a single publication 45 which had data from frontal cortex, visual cortex 717 
and cerebellum. The cerebellum data was not used here. Data from frontal and visual cortices were 718 
analyzed separately. All other datasets were used as described in our previous publication 12. The 719 
code and data for this analysis are available as an R package (see code availability below).  720 
 721 
GO term enrichment 722 
We tested whether genes that were highly specific to a trait-associated cell type (top 20% in a given 723 
cell type) AND highly associated with the genetics of the traits (top 10% MAGMA gene-level genetic 724 
association) were enriched in biological functions using the topGO R package 97. As background, we 725 
used genes that were highly specific to the cell type (top 20%) OR highly associated with the trait (top 726 
10% MAGMA gene-level genetic association). 727 
 728 
Page 15 of 54 
Parkinson’s disease rare variant enrichments 729 
We searched the literature for genes associated with Parkinsonism on the basis of rare and familial 730 
mutations. We found 66 genes (listed in Table S12). We used linear regression to test whether the z-731 
scaled specificity metric (per cell type) of the 66 genes were greater than 0 in the different cell types. 732 
 733 
Parkinson’s disease post-mortem transcriptomes 734 
The Moran dataset 47 was obtained from GEO (accession GSE8397). Processing of the U133a and 735 
U133b Cel files was done separately. The data was read in using the ReadAffy function from the R 736 
affy package 98, then Robust Multi-array Averaging (RMA) was applied. The U133a and U133b array 737 
expression data were merged after applying RMA. Probe annotations and mapping to HGNC symbols 738 
was done using the biomaRt R package 99. Differential expression analysis was performed using 739 
limma 100 taking age and gender as covariates. The Lesnick dataset 46 was obtained from GEO 740 
(accession GSE7621). Data was processed as for the Moran dataset: however, age was not available 741 
to use as a covariate. The Disjkstra dataset 50 was obtained from GEO (accession GSE49036) and 742 
processed as above: the gender and RIN values were used as covariates. As the transcriptome 743 
datasets measured gene expression in the substantia nigra, we only kept cell types that are present 744 
in the substantia nigra or ventral midbrain for our EWCE 11 analysis. We computed a new specificity 745 
matrix based on the substantia nigra or ventral midbrain cells from the Zeisel dataset (level 5) using 746 
EWCE 11. The EWCE analysis was performed on the 500 most up or down regulated genes using 747 
10,000 bootstrapping replicates. 748 
 749 
Code availability 750 
The code used to generate these results is available at: https://github.com/jbryois/scRNA_disease. 751 
An R package for performing cell type enrichments using magma is also available from: 752 
https://github.com/NathanSkene/MAGMA_Celltyping. 753 
 754 
Data availability 755 
All single-cell expression data are publicly available. Most summary statistics used in this study are 756 
publicly available. The migraine GWAS can be obtained by contacting the authors 77. The Parkinson’s 757 
disease summary statistics from 23andMe can be obtained under an agreement that protects the 758 
privacy of 23andMe research participants (https://research.23andme.com/collaborate/#publication ).  759 
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Figure 1: Study design and tissue-level associations. Heat map of trait – tissue/cell types associations 831 
(-log10P) for the  selected traits. (A) Trait – tissue/cell types associations were performed using 832 
MAGMA and LDSC (testing for enrichment in genetic association of the top 10% most specific genes 833 
in each tissue/cell type). (B) Tissue – trait associations for selected brain related traits. (C) Tissue – 834 
trait associations for selected non-brain related traits. (D) The mean strength of association (-log10P) 835 
of MAGMA and LDSC is shown and the bar color indicates whether the tissue is significantly 836 
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 839 
Figure 2: Association of selected brain related traits with cell types from the entire nervous system. 840 
Associations of the top 10 most associated cell types are shown. (A) Conditional analysis results for 841 
Parkinson’s disease using MAGMA. The label indicates the cell type the association analysis is being 842 
conditioned on. (B) The mean strength of association (-log10P) of MAGMA and LDSC is shown and 843 
the bar color indicates whether the cell type is significantly associated with both methods, one method 844 
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 847 
Figure 3: Replication of cell type – trait associations in mouse datasets. Tissue – trait associations 848 
are shown for the 10 most association cell types among 88 cell types from 9 different brain regions. 849 
(A) Tissue – trait associations are shown for the 10 most association cell types among 24 cell types 850 
from 5 different brain regions. (B) The mean strength of association (-log10P) of MAGMA and LDSC 851 
is shown and the bar color indicates whether the cell type is significantly associated with both 852 
methods, one method or none (significance threshold: 5 % false discovery rate). 853 
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 855 
Figure 4: Human replication of cell type – trait associations. Cell type - trait associations for 15 cell 856 
types (derived from single-nuclei RNA-seq) from 2 different brain regions (cortex, hippocampus). (A) 857 
Cell type - trait associations for 31 cell types (derived from single-nuclei RNA-seq) from 3 different 858 
brain regions (frontal cortex, visual cortex and cerebellum). (B) The mean strength of association (-859 
log10P) of MAGMA and LDSC is shown and the bar color indicates whether the cell type is significantly 860 
associated with both methods, one method or none (significance threshold: 5% false discovery rate). 861 
INT (intelligence), SCZ (schizophrenia), EDU (educational attainment), NEU (neuroticism), BMI (body 862 
mass index), BIP (bipolar disorder), MDD (Major depressive disorder), MEN (age at menarche), ASD 863 
(autism spectrum disorder), MIG (migraine), PAR (Parkinson’s disease), ADHD (attention deficit 864 
hyperactivity disorder), ICV (intracranial volume), HIP (hippocampal volume), AN (anorexia nervosa), 865 
ALZ (Alzheimer’s disease), ALS (amyotrophic lateral sclerosis), STR (stroke). 866 
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 868 
Figure 5: Enrichment of Parkinson’s disease differentially expressed genes in cell types from the 869 
substantia nigra. Enrichment of the 500 most up/down regulated genes (Braak stage 0 vs Braak stage 870 
1—2, 3—4 and 5—6, as well as cases vs controls) in postmortem human substantia nigra gene 871 
expression samples. The enrichments were obtained using EWCE11. A star shows significant 872 
enrichments after multiple testing correction (P<0.05/(25*6).  873 
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Supplementary Figures 876 
 877 
 878 
Figure S1: Manhattan plot of Parkinson’s disease meta-analysis. The black dotted line represents 879 
the genome-wide significance threshold (5x10-8).  880 
 881 
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 882 
Figure S2: Genetic correlation across traits. The genetic correlation across traits were computed 883 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































Type 2 diabetes adjusted for BMI





















Page 25 of 54 
 886 
Figure S3: Enrichment of immune genes in GTEx tissues. Enrichment pvalues of genes belonging to 887 
the GO term “Immune System Process” in the 10% most specific genes in each tissue. The one-sided 888 
pvalues were computed using linear regression, testing whether the average specificity metric of the 889 
gene set was higher than 0 (z-scaled specificity metrics per tissue). The GO term was selected 890 
because it is the most associated with inflammatory bowel disease using MAGMA. 891 
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 893 
Figure S4: Tissue – trait associations for all traits. The mean strength of association (-log10P) of 894 
MAGMA and LDSC is shown and the bar color indicates whether the tissue is significantly associated 895 
with both methods, one method or none (significance threshold: 5% false discovery rate). 896 
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 897 
 898 
Figure S5: Associations of brain related traits with cell types from the entire mouse nervous system. 899 
Associations of the top 15 most associated cell types are shown. The mean strength of association (-900 
log10P) of MAGMA and LDSC is shown and the bar color indicates whether the cell type is significantly 901 
associated with both methods, one method or none (significance threshold: 5% false discovery rate). 902 
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 904 
Figure S6: Correlation in cell type associations across traits. The Spearman rank correlations 905 
between the cell types associations across traits (-log10P) are shown. SCZ (schizophrenia), EDU 906 
(educational attainment), INT (intelligence), BMI (body mass index), BIP (bipolar disorder), NEU 907 
(neuroticism), PAR (Parkinson’s disease), MDD (Major depressive disorder), MEN (age at menarche), 908 
ICV (intracranial volume), ASD (autism spectrum disorder), STR (stroke), AN (anorexia nervosa), MIG 909 
(migraine), ALS (amyotrophic lateral sclerosis), ADHD (attention deficit hyperactivity disorder), ALZ 910 
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 913 
Figure S7: GWAS signal to noise ratio (λGC) by category of GWAS trait. Boxplot of the λGC of the 914 
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 917 
Figure S8: Number of single cells forming the oligodendrocyte cluster. Number of single cells per 918 
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 922 
Figure S9: Associations of brain related traits with neurons from the central nervous system. 923 
Associations of the 15 most associated neurons from the central nervous system (CNS) are shown. 924 
The specificity metrics were computed only using neurons from the CNS. The mean strength of 925 
association (-log10P) of MAGMA and LDSC is shown and the bar color indicates whether the cell type 926 
is significantly associated with both methods, one method or none (significance threshold: 5% false 927 
discovery rate). 928 
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 930 
Figure S10: Associations of cell types with schizophrenia/intelligence conditioning on gene-level 931 
genetic association of intelligence/schizophrenia. MAGMA association strength for each cell type 932 
before and after conditioning on gene-level genetic association for another trait. The black bar 933 
represents the significance threshold (5% false discovery rate). SCZ (schizophrenia), INT 934 
(intelligence).  935 
 936 
 937 
Figure S11: Associations of cell types with schizophrenia/educational attainment conditioning on 938 
gene-level genetic association of educational attainment/schizophrenia. MAGMA association strength 939 
for each cell type before and after conditioning on gene-level genetic association for another trait. The 940 
black bar represents the significance threshold (5% false discovery rate). SCZ (schizophrenia), EDU 941 
(educational attainment). 942 
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 944 
Figure S12: Conditional analysis results for brain related traits. Conditional analysis results using 945 
MAGMA are shown for up to the 5 most associated cell types (if at least 5 cell types were significant 946 
at a 5% false discovery rate in the original analysis. The color indicates if the cell type is significant at 947 
a 5% false discovery rate and the label indicates the cell type the association analysis is being 948 
conditioned on. 949 
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 951 
Figure S13: Replication of cell type – trait associations in 88 cell types from 9 different brain regions. 952 
The mean strength of association (-log10P) of MAGMA and LDSC is shown and the bar color indicates 953 
whether the cell type is significantly associated with both methods, one method or none (significance 954 
threshold: 5% false discovery rate). SCZ (schizophrenia), EDU (educational attainment), INT 955 
(intelligence), BMI (body mass index), BIP (bipolar disorder), NEU (neuroticism), PAR (Parkinson’s 956 
disease), MDD (Major depressive disorder), MEN (age at menarche), ICV (intracranial volume), ASD 957 
(autism spectrum disorder), STR (stroke), AN (anorexia nervosa), MIG (migraine), ALS (amyotrophic 958 
lateral sclerosis), ADHD (attention deficit hyperactivity disorder), ALZ (Alzheimer’s disease), HIP 959 
(hippocampal volume). 960 
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 962 
Figure S14: Top associated cell types with brain related traits among 88 cell types from 9 different 963 
brain regions. The mean strength of association (-log10P) of MAGMA and LDSC is shown for the 15 964 
top cell types for each trait. The bar color indicates whether the cell type is significantly associated 965 
with both methods, one method or none (significance threshold: 5% false discovery rate). 966 
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 968 
Figure S15: Correlation in cell type associations across traits in a replication data set (88 cell types, 969 
9 brain regions). Spearman rank correlations for cell types associations (-log10P) across traits are 970 
shown. SCZ (schizophrenia), EDU (educational attainment), INT (intelligence), BMI (body mass 971 
index), BIP (bipolar disorder), NEU (neuroticism), PAR (Parkinson’s disease), MDD (Major depressive 972 
disorder), MEN (age at menarche), ICV (intracranial volume), ASD (autism spectrum disorder), STR 973 
(stroke), AN (anorexia nervosa), MIG (migraine), ALS (amyotrophic lateral sclerosis), ADHD (attention 974 
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 977 
Figure S16: Associations of brain related traits with neurons from 9 different brain regions. Trait – 978 
neuron association are shown for neurons of the 9 different brain regions. The specificity metrics were 979 
computed only using neurons. The mean strength of association (-log10P) of MAGMA and LDSC is 980 
shown and the bar color indicates whether the cell type is significantly associated with both methods, 981 
one method or none (significance threshold: 5% false discovery rate). 982 
 983 
Hippocampal volume
Age at menarche Autism Parkinson's disease
Major depressive disorder Anorexia Intracranial volume
BMI Neuroticism Bipolar
Educational attainment Intelligence Schizophrenia
0 2 4 6
0 2 4 6 0 2 4 6
Substantia nigra & ventral tegmental area − Neuron
Cerebellum − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Striatum − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Hippocampus − Neuron
Thalamus − Neuron
Posterior Cortex − Neuron
Frontal Cortex − Neuron
Substantia nigra & ventral tegmental area − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Cerebellum − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Striatum − Neuron
Hippocampus − Neuron
Frontal Cortex − Neuron
Thalamus − Neuron
Posterior Cortex − Neuron
Substantia nigra & ventral tegmental area − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Striatum − Neuron
Frontal Cortex − Neuron
Cerebellum − Neuron
Globus pallidus externus & nucleus basalis − Neuron




Globus pallidus externus & nucleus basalis − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Posterior Cortex − Neuron
Substantia nigra & ventral tegmental area − Neuron
Striatum − Neuron




Entopdeduncular & subthalamic nuclei − Neuron




Globus pallidus externus & nucleus basalis − Neuron
Posterior Cortex − Neuron
Frontal Cortex − Neuron




Substantia nigra & ventral tegmental area − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Thalamus − Neuron
Posterior Cortex − Neuron
Frontal Cortex − Neuron
Substantia nigra & ventral tegmental area − Neuron
Cerebellum − Neuron
Hippocampus − Neuron
Frontal Cortex − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Thalamus − Neuron
Striatum − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Posterior Cortex − Neuron
Cerebellum − Neuron
Striatum − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Frontal Cortex − Neuron
Posterior Cortex − Neuron
Hippocampus − Neuron
Substantia nigra & ventral tegmental area − Neuron
Thalamus − Neuron
Substantia nigra & ventral tegmental area − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Cerebellum − Neuron
Hippocampus − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Thalamus − Neuron
Striatum − Neuron
Frontal Cortex − Neuron
Posterior Cortex − Neuron
Striatum − Neuron
Thalamus − Neuron
Substantia nigra & ventral tegmental area − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Cerebellum − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Hippocampus − Neuron
Posterior Cortex − Neuron
Frontal Cortex − Neuron
Hippocampus − Neuron
Striatum − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Cerebellum − Neuron
Substantia nigra & ventral tegmental area − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Frontal Cortex − Neuron
Thalamus − Neuron
Posterior Cortex − Neuron
Substantia nigra & ventral tegmental area − Neuron





Entopdeduncular & subthalamic nuclei − Neuron
Frontal Cortex − Neuron
Posterior Cortex − Neuron
Frontal Cortex − Neuron
Cerebellum − Neuron
Hippocampus − Neuron
Posterior Cortex − Neuron
Thalamus − Neuron
Substantia nigra & ventral tegmental area − Neuron
Globus pallidus externus & nucleus basalis − Neuron
Entopdeduncular & subthalamic nuclei − Neuron
Striatum − Neuron
Mean(−log10(pvalue))
Schizophrenia Intelligence MDD Parkinson
0 5 10 0 5 10 0 5 10 0 5 10
Brain − Substantia nigra
Brain − Spinal cord (cervical c−1)
Brain − Cerebellum




Brain − Putamen (basal ganglia)
Brain − Caudate (basal ganglia)
Brain − Nucleus accumbens (basal ganglia)
Brain − Frontal Cortex (BA9)
Brain − Cortex































Page 38 of 54 
 984 
Figure S17: Top associated cell types with brain related traits among 24 cell types from 5 different 985 
brain regions. The mean strength of association (-log10P) of MAGMA and LDSC is shown for the 15 986 
top cell types for each trait. The bar color indicates whether the cell type is significantly associated 987 
with both methods, one method or none (significance threshold: 5% false discovery rate). 988 
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 990 
Figure S18: Top associated neurons with brain related traits among 16 neurons from 5 different brain 991 
regions. The specificity metrics were computed only using neurons. The mean strength of association 992 
(-log10P) of MAGMA and LDSC is shown for the top 15 cell types for each trait. The bar color indicates 993 
whether the cell type is significantly associated with both methods, one method or none (significance 994 
threshold= 5% false discovery rate). 995 
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 997 
Figure S19: Single nuclei datasets are systematically depleted of dendritically enriched transcripts 998 
relative to single-cell datasets. Each bar represents a comparison between two datasets (X versus 999 
Y), with the bootstrapped z-scores representing the extent to which dendritically enriched transcripts 1000 
96 have lower specificity for pyramidal neurons in dataset Y relative to that in dataset X. Larger z-1001 
scores indicate greater depletion of dendritically enriched transcripts, and red bars indicate a 1002 
statistically significant depletion (P < 0.05, by bootstrapping).  1003 
 1004 
 1005 
Figure S20: Association of Parkinson’s disease with oligodendrocytes in the different datasets. The 1006 
dotted line indicated the nominal significance threshold (P=0.05) 1007 
 1008 
 1009 
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 1010 
Figure S21: Gene expression correlation within cell type across species. Pearson correlation of gene 1011 
expression (log2(expression) +1) between mouse and human cell types with matching names (from 1012 
Habib et al. 2017 42). 1013 
 1014 
 1015 
Figure S22: Quantile-quantile plot of Parkinson’s disease meta-analysis. Quantile-quantile plot of the 1016 
meta-analyzed pvalues for Parkinson’s disease. The y-axis is truncated for clarity. The grey zone 1017 
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 1020 
Figure S23: Jaccard index for the top 10% most specific genes in each tissue in the GTEx dataset. 1021 
Jaccard index were calculated between the top 10% most specific genes in each tissue from the 1022 
































Brain − Anterior cingulate cortex (BA24)
Brain − Cortex
Brain − Frontal Cortex (BA9)
Brain − Nucleus accum
bens (basal ganglia)









Brain − Cerebellar Hem
isphere
Brain − Cerebellum
Brain − Spinal cord (cervical c−1)

























Brain − Anterior cingulate cortex (BA24)
Brain − Cortex
Brain − Frontal Cortex (BA9)
Brain − Nucleus accumbens (basal ganglia)
Brain − Caudate (basal ganglia)




Brain − Cerebellar Hemisphere
Brain − Cerebellum
Brain − Spinal cord (cervical c−1)






Page 43 of 54 
 1025 
Figure S24: Jaccard index for the top 10% most specific genes in each cell type in the mouse nervous 1026 
system (Zeisel et al. 2018). Jaccard index were calculated between the top 10% most specific genes 1027 
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 1030 
Figure S25: Correlation between beta coefficient and significance level. Histograms of the spearman 1031 
rank correlations between effect size (beta coefficient) and significance (-log10P) computed for each 1032 
trait in the Zeisel dataset. The effect sizes are strongly correlated with the significance level of the cell 1033 
type with values ranging from 0.999 to 1 using MAGMA and 0.953 to 1 with LDSC. 1034 
 1035 
 1036 
Figure S26: Number of MAGMA associations with P<0.05 using permuted gene-level genetic 1037 
associations. Gene labels were randomly permuted a thousand times for the schizophrenia MAGMA 1038 
gene-level genetic associations (39 cell types * 1000 permuted labels=39,000 associations with 1039 
permuted gene labels). The number of permutations with P < 0.05 is shown in blue. The black 1040 
horizontal bar shows expected number of random associations with P < 0.05 (39,000*0.05=1950). 1041 
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 1043 
Figure S27: Correlation in schizophrenia cell type association strengths with different window sizes 1044 
using MAGMA. Pearson correlations of the cell type association strength (-log10P) across different 1045 
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 1049 
Figure S28: Correlation in schizophrenia cell type association strengths with different window sizes 1050 
and percentages of most specific genes using LDSC. Pearson correlations of the cell type association 1051 
strength (-log10P) across different window sizes and percentages of most specific genes using LDSC. 1052 
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 1056 
Figure S29: Correlation between 𝜆$% and similarity in cell type ordering between MAGMA and LDSC. 1057 
LDSC101 was used to obtain 𝜆$%	(a measure of the deviation of the GWAS statistics from the expected) 1058 
for each GWAS. Spearman rank correlation was used to test for similarity in association strength (-1059 
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 1062 
Figure S30: Correlation between mean number of significant cell types and similarity in cell type 1063 
ordering between MAGMA and LDSC. The mean number of cell types was obtained by taking the 1064 
average of the number of cell types that were significantly associated with each trait (FDR<5%) using 1065 
MAGMA and LDSC. Spearman rank correlation was used to test for similarity in association strength 1066 
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 1069 
Figure S31: The GWAS λGC is correlated with the strength of association of the top cell type in the 1070 
Zeisel dataset. Scatter plot of the λGC (median of chi-squared test statistics divided by expected 1071 
median of the chi-squared distribution) of each GWAS vs the strength of association of the top Zeisel 1072 
cell type associated with the trait (-log10(PMAGMA)). Spearman correlation=0.88 (A). Scatter plot of the 1073 
λGC of each GWAS vs the effect size of the top Zeisel cell type associated with the trait (-1074 
log10(PMAGMA)). Spearman correlation=0.9 (B). Scatter plot of the strength of association of the top 1075 
Zeisel cell type (-log10(PMAGMA)) of each GWAS vs the effect size of the top Zeisel cell type. Spearman 1076 
correlation=0.996 (C). 1077 
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